ADAG
Price
$1.81
Change
-$0.17 (-8.59%)
Updated
Nov 19 closing price
Capitalization
85.31M
13 days until earnings call
Intraday BUY SELL Signals
NEVPF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 23 closing price
Capitalization
45.13M
Intraday BUY SELL Signals
Interact to see
Advertisement

ADAG vs NEVPF

Header iconADAG vs NEVPF Comparison
Open Charts ADAG vs NEVPFBanner chart's image
Adagene
Price$1.81
Change-$0.17 (-8.59%)
Volume$36.82K
Capitalization85.31M
Abliva AB
Price$0.03
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
ADAG vs NEVPF Comparison Chart in %
ADAG
Daily Signal:
Gain/Loss:
NEVPF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADAG vs. NEVPF commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and NEVPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ADAG: $1.81 vs. NEVPF: $0.03)
Brand notoriety: ADAG and NEVPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 49% vs. NEVPF: 100%
Market capitalization -- ADAG: $85.31M vs. NEVPF: $45.13M
ADAG [@Biotechnology] is valued at $85.31M. NEVPF’s [@Biotechnology] market capitalization is $45.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileNEVPF’s FA Score has 0 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • NEVPF’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADAG and NEVPF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 5 TA indicator(s) are bullish while NEVPF’s TA Score has 1 bullish TA indicator(s).

  • ADAG’s TA Score: 5 bullish, 4 bearish.
  • NEVPF’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, ADAG is a better buy in the short-term than NEVPF.

Price Growth

ADAG (@Biotechnology) experienced а +2.26% price change this week, while NEVPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

ADAG is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADAG($85.3M) has a higher market cap than NEVPF($45.1M). ADAG YTD gains are higher at: -9.045 vs. NEVPF (-22.222). ADAG has higher annual earnings (EBITDA): -29.17M vs. NEVPF (-87.99M). ADAG has more cash in the bank: 62.8M vs. NEVPF (32.7M). ADAG has higher revenues than NEVPF: ADAG (103K) vs NEVPF (0).
ADAGNEVPFADAG / NEVPF
Capitalization85.3M45.1M189%
EBITDA-29.17M-87.99M33%
Gain YTD-9.045-22.22241%
P/E RatioN/AN/A-
Revenue103K0-
Total Cash62.8M32.7M192%
Total Debt6.85MN/A-
FUNDAMENTALS RATINGS
NEVPF: Fundamental Ratings
NEVPF
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
7

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGNEVPF
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 2 days ago
13%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 2 days ago
13%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADAG
Daily Signal:
Gain/Loss:
NEVPF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA403.992.74
+0.68%
Tesla
AAPL268.561.12
+0.42%
Apple
SPY662.632.55
+0.39%
SPDR® S&P 500® ETF
GME20.42-0.08
-0.39%
GameStop Corp
BTC.X91465.990000-1482.882800
-1.60%
Bitcoin cryptocurrency

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been closely correlated with MLTX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NEVPF jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
MLTX - NEVPF
70%
Closely correlated
+1.12%
IMA - NEVPF
66%
Loosely correlated
-4.19%
ATYR - NEVPF
65%
Loosely correlated
-3.27%
CELC - NEVPF
61%
Loosely correlated
+2.87%
INBX - NEVPF
59%
Loosely correlated
+5.86%
More